Pope, J. H., Horne, M. K. & Scott, W. Transformation of foetal human keukocytes in vitro by filtrates of a human leukaemic cell line containing herpes-like virus. Int. J. Cancer 3, 857–866 (1968).
Hsu, J. L. & Glaser, S. L. Epstein-Barr virus-associated malignancies: epidemiologic patterns and etiologic implications. Crit. Rev. Oncol. Hematol. 34, 27–53 (2000).
Thorley-Lawson, D. A. & Gross, A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N. Engl. J. Med. 350, 1328–1337 (2004).
Rawlins, D. R., Milman, G., Hayward, S. D. & Hayward, G. S. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42, 859–868 (1985).
Bochkarev, A. et al. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein EBNA 1. Cell 83, 39–46 (1995).
Bochkarev, A. et al. Crystal structure of the DNA-binding domain of the Epstein-Barr virus origin-binding protein, EBNA1, bound to DNA. Cell 84, 791–800 (1996).
Sears, J. et al. The amino terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J. Virol. 78, 11487–11505 (2004).
De Leo, A., Calderon, A. & Lieberman, P. M. Control of viral latency by episome maintenance proteins. Trends Microbiol. 28, 150–162 (2020).
Humme, S. et al. The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc. Natl Acad. Sci. USA 100, 10989–10994 (2003).
Altmann, M. et al. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV’s transforming genes. Proc. Natl Acad. Sci. USA 103, 14188–14193 (2006).
Frappier, L. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 4, 1537–1547 (2012).
Lu, F. et al. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr virus nuclear antigen 1 (EBNA1). Virol. J. 7, 262 (2010).
Tempera, I. et al. Identification of MEF2B, EBF1, and IL6R as direct gene targets of Epstein-Barr virus (EBV) nuclear antigen 1 critical for EBV-infected B-lymphocyte survival. J. Virol. 90, 345–355 (2016).
Kim, K. D. et al. Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus. Nat. Commun. 11, 877 (2020).
Kanda, T., Kamiya, M., Maruo, S., Iwakiri, D. & Takada, K. Symmetrical localization of extrachromosomally replicating viral genomes on sister chromatids. J. Cell Sci. 120, 1529–1539 (2007).
Wang, H. et al. CRISPR-mediated programmable 3D genome positioning and nuclear organization. Cell 175, 1405–1417 (2018).
Chen, B. et al. Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system. Cell 155, 1479–1491 (2013).
Ambinder, R. F., Mullen, M. A., Chang, Y. N., Hayward, G. S. & Hayward, S. D. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 65, 1466–1478 (1991).
Ambinder, R. F., Shah, W. A., Rawlins, D. R., Hayward, G. S. & Hayward, S. D. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 64, 2369–2379 (1990).
Brown, R. E. & Freudenreich, C. H. Structure-forming repeats and their impact on genome stability. Curr. Opin. Genet. Dev. 67, 41–51 (2021).
Wang, G. & Vasquez, K. M. Dynamic alternative DNA structures in biology and disease. Nat. Rev. Genet. 24, 211–234 (2023).
Durkin, S. G. & Glover, T. W. Chromosome fragile sites. Annu. Rev. Genet. 41, 169–192 (2007).
Glover, T. W., Wilson, T. E. & Arlt, M. F. Fragile sites in cancer: more than meets the eye. Nat. Rev. Cancer 17, 489–501 (2017).
Yunis, J. J. The chromosomal basis of human neoplasia. Science 221, 227–236 (1983).
Yunis, J. J. & Soreng, A. L. Constitutive fragile sites and cancer. Science 226, 1199–1204 (1984).
Yu, S. et al. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88, 367–374 (1997).
Boteva, L. et al. Common fragile sites are characterized by faulty condensin loading after replication stress. Cell Rep. 32, 108177 (2020).
Sfeir, A. et al. Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138, 90–103 (2009).
Bashaw, J. M. & Yates, J. L. Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA. J. Virol. 75, 10603–10611 (2001).
Malik-Soni, N. & Frappier, L. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. J. Virol. 86, 6999–7002 (2012).
Umbreit, N. T. et al. Mechanisms generating cancer genome complexity from a single cell division error. Science 368, eaba0712 (2020).
Lee, J. H. & Paull, T. T. Cellular functions of the protein kinase ATM and their relevance to human disease. Nat. Rev. Mol. Cell Biol. 22, 796–814 (2021).
Thirman, M. J. et al. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations. N. Engl. J. Med. 329, 909–914 (1993).
Fu, Y. H. et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67, 1047–1058 (1991).
van Wietmarschen, N. et al. Repeat expansions confer WRN dependence in microsatellite-unstable cancers. Nature 586, 292–298 (2020).
Lieberman, P. M. Keeping it quiet: chromatin control of gammaherpesvirus latency. Nat. Rev. Microbiol. 11, 863–875 (2013).
Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
Kato, H. & Sandberg, A. A. Chromosome pulverization in human cells with micronuclei. J. Natl Cancer Inst. 40, 165–179 (1968).
Zhang, C. Z. et al. Chromothripsis from DNA damage in micronuclei. Nature 522, 179–184 (2015).
Ly, P. et al. Selective Y centromere inactivation triggers chromosome shattering in micronuclei and repair by non-homologous end joining. Nat. Cell Biol. 19, 68–75 (2017).
Leibowitz, M. L. et al. Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing. Nat. Genet. 53, 895–905 (2021).
Cortés-Ciriano, I. et al. Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing. Nat. Genet. 52, 331–341 (2020).
Young, L. S. & Rickinson, A. B. Epstein-Barr virus: 40 years on. Nat. Rev. Cancer 4, 757–768 (2004).
Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K. & Raab-Traub, N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333, 693–698 (1995).
Bruce, J. P. et al. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape. Nat. Commun. 12, 4193 (2021).
Li, Y. Y. et al. Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations. Nat. Commun. 8, 14121 (2017).
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82–93 (2020).
Zapatka, M. et al. The landscape of viral associations in human cancers. Nat. Genet. 52, 320–330 (2020).
Sivachandran, N., Wang, X. & Frappier, L. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J. Virol. 86, 6146–6158 (2012).
Guo, R. et al. MYC controls the Epstein-Barr virus lytic switch. Mol. Cell 78, 653–669 (2020).
Chien, Y. C. et al. Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N. Engl. J. Med. 345, 1877–1882 (2001).
Ambinder, R. F. Gammaherpesviruses and “hit-and-run” oncogenesis. Am. J. Pathol. 156, 1–3 (2000).
Shoshani, O. et al. Chromothripsis drives the evolution of gene amplification in cancer. Nature 591, 137–141 (2021).
Celli, G. B. & de Lange, T. DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat. Cell Biol. 7, 712–718 (2005).
The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 513, 202–209 (2014).
More News
Author Correction: Stepwise activation of a metabotropic glutamate receptor – Nature
Changing rainforest to plantations shifts tropical food webs
Streamlined skull helps foxes take a nosedive